Cisplatin neuropathy: clinical course and neurophysiological findings.
Sixteen patients treated with cisplatin (CDDP) 40 mg/m2 on days 1-5 every 4 weeks for three courses (cumulative dose 600 mg/m2) were clinically and neurophysiologically tested before, during and 1, 3, 6, 9 and 12 months after CDDP administration. The first symptoms of polyneuropathy occurred in 4 of 9 patients after the second course (cumulative dose 400 mg/m2). One month after treatment 1 of 9 patients was asymptomatic, 5 complained of symptoms and 3 showed clinical and neurophysiological signs of polyneuropathy. Three months after CDDP all patients were affected. Clinical and neurophysiological signs of severity progression were noted up to 6 months after treatment with CDDP.
21 references, click to expand
-
Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up.J Clin Oncol. 1988 Aug;6(8):1239-47 PMID: 2457658
-
Drug-induced peripheral neuropathies.Br Med J. 1979 Mar 10;1(6164):663-6 PMID: 219931
-
Ophthalmologic toxicity after cis-dichlorodiammineplatinum(II) therapy.Cancer Treat Rep. 1978 Oct;62(10):1591-4 PMID: 709562
-
Severe sensorimotor neuropathy after cisplatin therapy.J Neurol Neurosurg Psychiatry. 1986 Mar;49(3):333-4 PMID: 3007678
-
cis-Platinum-induced hypomagnesemia and peripheral neuropathy.Gynecol Oncol. 1983 Dec;16(3):309-18 PMID: 6317526
-
Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.Cancer. 1984 Oct 1;54(7):1269-75 PMID: 6088023
-
Polyneuropathy induced by cisplatin.Prog Exp Tumor Res. 1985;29:190-6 PMID: 2999870
-
Cisplatin neuropathy with Lhermitte's sign.J Neurol Neurosurg Psychiatry. 1986 Jan;49(1):96-9 PMID: 3007675
-
Electrophysiological study of the peripheral and central neurotoxic effect of cis-platin.Acta Neurol Scand. 1987 Aug;76(2):86-93 PMID: 3673502
-
Prospective nerve conduction studies in cisplatin therapy.Ann Neurol. 1988 Jan;23(1):92-4 PMID: 3345071
-
Sensorimotor neuropathy and cisplatin and adriamycin toxicity.J Neurol Neurosurg Psychiatry. 1986 Aug;49(8):964-5 PMID: 3018171
-
Peripheral sensory neuropathy and cisplatin chemotherapy.Neurology. 1984 Jul;34(7):934-8 PMID: 6330613
-
Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old man.Cancer. 1980 Feb 15;45(4):764-6 PMID: 7188878
-
Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer.J Clin Oncol. 1989 Oct;7(10):1457-61 PMID: 2476531
-
Neurotoxicity of antineoplastic drugs.Semin Oncol. 1982 Mar;9(1):103-30 PMID: 6280320
-
Drug-induced peripheral neuropathies.Br Med J. 1979 Apr 7;1(6168):955 PMID: 219936
-
Unusual presentation of cis-platinum neuropathy.Neurology. 1988 Mar;38(3):488-90 PMID: 3347355
-
Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum II.J Cancer Res Clin Oncol. 1980;96(2):219-22 PMID: 6248563
-
Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.Cancer. 1988 Jun 1;61(11):2192-5 PMID: 2835140
-
[Neuropathy caused by cisplatin. Clinical, electrophysiological and morphological study].Rev Neurol (Paris). 1985;141(10):614-26 PMID: 3003868
-
Nerve conduction studies in patients treated with cis-diamminedichloroplatinum(II): a preliminary report.Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1119-22 PMID: 7193088
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
